Login / Signup
Reasons why treatment of metabolic dysfunction-associated steatotic liver disease may benefit from targeting the gut-liver axis as well.
Claudia Mandato
Angelo Colucci
Pietro Vajro
Published in:
United European gastroenterology journal (2024)
Keyphrases
</>
oxidative stress
combination therapy
drug delivery